Monday, February 29, 2016
Aldeyra Therapeutics Inc said its experimental eye drug proved to be more effective than a placebo in treating itching and tearing associated with allergic conjunctivitis in a mid-stage study.
Allergic conjunctivitis is a common disease characterized by an inflammation of the membrane that covers the eye, which results in excessive tear production, ocular itching, swelling, and redness.
uk.reuters.com
